Atricure Inc. buy Needham & Company LLC
Start price
10.04.24
/
50%
€33.20
Target price
10.04.25
€42.66
Performance (%)
-
End price
11.04.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | 7.792% | 7.792% | -46.452% |
| iShares Core DAX® | 0.760% | 1.149% | 17.258% |
| iShares Nasdaq 100 | 0.732% | 1.884% | 8.152% |
| iShares Nikkei 225® | 1.025% | -0.865% | 13.066% |
| iShares S&P 500 | -0.036% | 1.480% | 3.393% |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $46.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten